论文部分内容阅读
近年发展起来的TSH免疫放射分析法(IRMA)是一种具有较高灵敏度的检查方法,可作为反映垂体-甲状腺轴功能的指标。血清游离甲状腺激素(FT_4和FT_3)与TSH IRMA联合应用,可判断血清甲状腺激素水平已有改变的全身性疾病患者,是否真正伴有甲状腺本身的疾病。因此,本文用这种方法观察了溃疡病,肝硬化和肝癌患者的垂体-甲状腺功能,现将结果报道如下。 材料和方法 一,对象: (一)溃疡病组:活动期胃、十二指肠溃疡病患者30例(男22,女8),年龄21～49岁。 (二)溃疡病出血组:胃、十二指肠溃疡并出血患者26例(男17,女9),年龄25岁～46岁。 (三)肝硬化组:肝硬化患者38例(男30,女8),年龄32岁～89岁,其中19例有不同程度腹水(肝功能失代偿期)。 (四)肝癌组:原发性肝癌患者20例(男18,女2),年龄30岁～65岁。 全部患者均为本院住院病人,经胃镜,肝功能、AFP、B超,CT等检查确诊,均无甲状腺疾病史及家
The TSH immuno-radiometric assay (IRMA), developed in recent years, is a highly sensitive test that can be used as an indicator of pituitary-thyroid axis function. Serum free thyroid hormones (FT_4 and FT_3) combined with TSH IRMA, can determine the serum thyroid hormone levels have changed in patients with systemic diseases, whether the real thyroid itself with the disease. Therefore, this article observed in this way ulcer disease, cirrhosis and liver cancer in patients with pituitary-thyroid function, the results reported below. Materials and methods First, the object: (a) ulcer disease group: active stomach, duodenal ulcer patients 30 (male 22, female 8), aged 21 to 49 years old. (B) ulcer bleeding group: stomach, duodenal ulcer and bleeding in patients with 26 cases (male 17, female 9), aged 25 to 46 years old. (C) cirrhosis group: 38 patients with cirrhosis (male 30, female 8), aged 32 to 89 years of age, of which 19 cases of varying degrees of ascites (decompensated liver). (D) liver cancer group: 20 patients with primary liver cancer (male 18, female 2), aged 30 to 65 years old. All patients were hospitalized patients in our hospital, by gastroscope, liver function, AFP, B ultrasound, CT and other tests confirmed, no history of thyroid disease and home